A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab

Patients with monoclonal gammopathy of renal significance should be treated with clone‐directed therapy against sources of monoclonal proteins in order to prevent progression to more advanced monoclonal gammopathies and renal failure.

Detalles Bibliográficos
Autores principales: Kuang, Chaoyuan, Quann, Kevin, Liman, Agnes K., Frye, Roy, Alshoubaki, Nawras, Ramkumar, Mohan, Liman, Andrew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562843/
https://www.ncbi.nlm.nih.gov/pubmed/33088534
http://dx.doi.org/10.1002/ccr3.3044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562843/
https://www.ncbi.nlm.nih.gov/pubmed/33088534
http://dx.doi.org/10.1002/ccr3.3044

Ejemplares similares